Session Information
Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s - Clinical Aspects and Therapeutics II
Session Type: Abstract Submissions (ACR)
Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disease associated with substantial morbidity. Epidemiologic studies using large administrative databases often rely on the accuracy of International Classification of Diseases-Clinical Modification-9 (ICD-CM-9) codes for case definitions of medical conditions such as SSc. A previous study of 89 hospitalized patients at a tertiary care center found that the accuracy of ICD-CM-9 code 710.1 for determining true cases of SSc that met the 1980 ACR criteria was 45%. We sought to determine the accuracy of the ICD-CM-9 code of 710.1 for identifying cases of SSc using a large outpatient cohort of well-characterized patients.
Methods: This was a retrospective analysis of the medical records of all patients evaluated at Stanford Hospital and Clinics from 2005-2012 who have an associated ICD-CM-9 code of 710.1. True cases of SSc were defined as any of the following: a) Fulfill the 1980 American College of Rheumatology (ACR) classification criteria for SSc; b) Have at least 3 of 5 of the CREST (calcinosis, Raynaud’s, esophageal dysmotility, sclerodactyly, telangiectasias) features; OR c) Fulfill preliminary ACR/European League Against Rheumatism (EULAR) revised criteria for the classification of SSc.
Results: 432 patient records were reviewed. Mean age was 57±14.5 years, 84% were female, 51% Caucasian. 21% had diffuse cutaneous disease, 66% had limited disease, and 3% were characterized as SSc sine sclerosis. 238 (55%) patients met the 1980 ACR criteria, 292 (68%) patients met CREST criteria, and 297 (69%) patients met the revised ACR/EULAR criteria. The accuracy of ICD-9-CM code 710.1 for determining true cases of SSc by any of the three classification criteria was 77%. The ICD-CM-9 code for SSc was accurate 71% of the time when the 1980 ACR criteria were applied, and 75% of the time when the CREST or ACR/EULAR revised criteria were applied.
Table 1: Clinical Characteristics of 432 Systemic Sclerosis Patients by Criteria
Classification Criteria |
Percentage of patients affected |
|
|
1980 ACR Criteria: |
|
Major criterion: |
|
Proximal diffuse (truncal) sclerosis (skin tightness, thickening, non-pitting induration) |
42% |
|
|
Minor criteria: |
|
|
63% |
|
25% |
|
29% |
|
|
Patients who met the major criterion or 2 minor criteria: |
55% |
|
|
CREST Criteria |
|
|
|
Calcinosis |
12% |
Raynaud’s Phenomenon |
82% |
Esophageal dysmotility |
60% |
Sclerodactyly |
63% |
Telangiectasias |
49% |
|
|
Patients who met 3 of 5 CREST criteria: |
68% |
|
|
Revised ACR/EULAR Criteria |
|
|
|
Skin thickening of the fingers |
|
puffy fingers |
25% |
whole finger distal to MCP |
47% |
|
|
Fingertip lesions |
|
digital ulcers |
28% |
pitting scars |
21% |
|
|
Abnormal nailfold capillaries |
33% |
|
|
Pulmonary involvement |
|
Pulmonary hypertension |
20% |
Interstitial lung disease |
29% |
|
|
Autoantibody profile |
|
Positive ANA |
62% |
Positive scl-70 Ab |
11% |
Positive anti-centromere Ab |
20% |
|
|
Patients who scored ≥ 9 points in the revised ACR/EULAR criteria: |
69% |
|
|
*Raynaud’s, telangiectasia percentages already noted above. |
|
Conclusion:
We found an acceptable accuracy rate of 77% for the ICD-CM-9 code 710.1 for determining true cases of SSc according to any of 3 different classification schemes. Our study supports the validity of this ICD-CM-9 code for identifying cases of SSc for epidemiologic studies using administrative databases.
Disclosure:
A. Yaqub,
None;
L. Chung,
None;
D. Fiorentino,
None;
E. Krishnan,
Takeda,
2,
takeda,
5.
« Back to 2013 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-the-icd-cm-9-code-for-systemic-sclerosis-using-updated-acreular-classification-criteria/